Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2004]
News [3351]
Articles [144]
Editorials [3]
Conferences [125]
elearning [18]
ASH 2025: Study suggests that a virtual programme focusing on diet and exercise can help reduce side effects of lymphoma treatment
ASH 2025: Study suggests that a virtual programme focusing on diet and exercise can help reduce side effects of...
ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer
ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer
FDA approves epcoritamab-bysp for follicular lymphoma indications
FDA approves epcoritamab-bysp for follicular lymphoma indications
Scientists can finally answer an old question about cellular ageing
Scientists can finally answer an old question about cellular ageing
Researchers lead major treatment overhauls for acute myeloid leukaemia
Researchers lead major treatment overhauls for acute myeloid leukaemia
New protocol for Treg expansion uses targeted immunotherapy to reduce transplant complications
New protocol for Treg expansion uses targeted immunotherapy to reduce transplant complications
Potential treatment to bypass resistance in deadly childhood cancer
Potential treatment to bypass resistance in deadly childhood cancer
SISAQOL-IMI consortium publishes key paper and launches online materials to advance patient-reported outcomes in cancer clinical trials
SISAQOL-IMI consortium publishes key paper and launches online materials to advance patient-reported outcomes in...
Much-needed new drug approved for deadliest blood cancer
Much-needed new drug approved for deadliest blood cancer
Particle accelerator waste could help produce cancer-fighting materials, study suggests
Particle accelerator waste could help produce cancer-fighting materials, study suggests

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation